Vibrational spectroscopic characterisation of salmeterol xinafoate polymorphs and a preliminary investigation of their transformation using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry.

Knowledge and control of the polymorphic phases of chemical compounds are important aspects of drug development in the pharmaceutical industry. Salmeterol xinafoate, a long acting beta-adrenergic receptor agonist, exists in two polymorphic Forms, I and II. Raman and near infrared spectra were obtained of these polymorphs at selected wavelengths in the range of 488-1064 nm; significant differences in the Raman and near-infrared spectra were apparent and key spectral marker bands have been identified for the vibrational spectroscopic characterisation of the individual polymorphs which were also characterised with X ray diffractometry. The solid-state transition of salmeterol xinafoate polymorphs was studied using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry isothermally between transitions. This method assisted in the unambiguous characterisation of the two polymorphic forms by providing a simultaneous probe of both the thermal and vibrational data. The study demonstrates the value of a rapid in situ analysis of a drug polymorph which can be of potential value for at-line in-process control.

[1]  U. Jayasooriya,et al.  Simultaneous application of Fourier transform Raman spectroscopy and differential scanning colorimetry for the in situ investigation of phase transitions in condensed matter , 1991 .

[2]  Peter York,et al.  FT-Raman spectroscopic investigation of a pseudopolymorphic transition in caffeine hydrate , 1998 .

[3]  Suryanarayanan,et al.  Applications of pressure differential scanning calorimetry in the study of pharmaceutical hydrates. I. Carbamazepine dihydrate. , 1997, International journal of pharmaceutics.

[4]  Andrew G. Glen,et al.  APPL , 2001 .

[5]  G. Stephenson,et al.  Physical characterization of polymorphic drugs: an integrated characterization strategy , 1998 .

[6]  Mauno E. E. Harju,et al.  Solid-State Transition Mechanisms of Ammonium Nitrate Phases IV, III, and II Investigated by Simultaneous Raman Spectrometry and Differential Scanning Calorimetry , 1993 .

[7]  H. Tong,et al.  Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized From Supercritical Fluids , 2001, Pharmaceutical Research.

[8]  X. Gu,et al.  Characterization of polymorphic forms of fluconazole using Fourier transform Raman spectroscopy. , 1995, Journal of pharmaceutical sciences.

[9]  B. Shekunov,et al.  Thermal Analysis of Trace Levels of Polymorphic Impurity in Salmeterol Xinafoate Samples , 2003, Pharmaceutical Research.

[10]  L. S. Taylor,et al.  Evaluation of solid-state forms present in tablets by Raman spectroscopy. , 2000, Journal of pharmaceutical sciences.

[11]  Y. Matsuda,et al.  Kinetic study of the polymorphic transformations of phenylbutazone. , 1984, Journal of pharmaceutical sciences.

[12]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[13]  B. Shekunov,et al.  Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine. , 2001, Journal of pharmaceutical sciences.

[14]  H. Wikström,et al.  In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. , 2005, Journal of pharmaceutical sciences.

[15]  Richard L. McCreery,et al.  Raman Spectroscopy for Chemical Analysis , 2000 .

[16]  J. Sprunt,et al.  Simultaneous FT-Raman Differential Scanning Calorimetry Measurements Using a Low-Cost Fiber-Optic Probe , 1997 .

[17]  T. Norris,et al.  Determination of end-points for polymorph conversions of crystalline organic compounds using on-line near-infrared spectroscopy , 1997 .

[18]  J. A. Wachter,et al.  An Investigation of Solvent-Mediated Polymorphic Transformation of Progesterone Using in Situ Raman Spectroscopy , 2000 .

[19]  E. Francotte,et al.  In Situ Characterization of Polymorphic Forms: The Potential of Raman Techniques , 1999 .

[20]  Jukka Rantanen,et al.  Polymorph screening using near-infrared spectroscopy , 2003 .

[21]  S. Lonardi,et al.  Near-infrared reflectance spectrometry in the determination of the physical state of primary materials in pharmaceutical production , 1995 .

[22]  J. Rantanen,et al.  Novel identification of pseudopolymorphic changes of theophylline during wet granulation using near infrared spectroscopy. , 2001, Journal of pharmaceutical sciences.

[23]  I. Hunter,et al.  Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes. , 2003, Journal of pharmaceutical sciences.

[24]  Reginald H. Wilson,et al.  A simultaneous FT-Raman–DSC (SRD) study of polymorphism in sn-1,3-distearoyl-2-oleoylglycerol (SOS) , 2000 .

[25]  S. Bell,et al.  Rapid analysis of ecstasy and related phenethylamines in seized tablets by Raman spectroscopy. , 2000, The Analyst.

[26]  George Turrell,et al.  Raman microscopy : developments and applications , 1996 .

[27]  I. B. Berlman.  Handbook of flourescence spectra of aromatic molecules , 1971 .

[28]  Peter York,et al.  Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs. , 2004, Journal of pharmaceutical and biomedical analysis.

[29]  George Jalsovszky,et al.  Investigation of the Morphological Composition of Cimetidine by FT-Raman Spectroscopy , 1995 .

[30]  P. Gemperline,et al.  Near-IR Detection of Polymorphism and Process-Related Substances , 1996 .

[31]  D. Giron.  Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvates , 1995 .

[32]  P. York,et al.  Control of the Physical Form of Salmeterol Xinafoate , 1999 .